INDSWIFT LABORATORIES
|
The Current P/S Ratio of INDSWIFT LABORATORIES is 1.85.
| Share Price | ₹135.1 | Feb 12,2026 |
| Market Cap | ₹1,102.4 Cr | |
| Sales-TTM | ₹594.5 Cr | TTM-Consolidated Results |
| Price/Sales | 1.85x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of INDSWIFT LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,102.4 Cr] as on Feb 12,2026
(/) Sales [ ₹594.5 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.85x ]
Thus, for INDSWIFT LABORATORIES , the investors are currently willing to pay '1.85 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of INDSWIFT LABORATORIES !
The chart below summarizes the trend in P/S Ratio of INDSWIFT LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of INDSWIFT LABORATORIES
PS Ratio Performance Analysis for INDSWIFT LABORATORIES
- INDSWIFT LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 0.52x.
- INDSWIFT LABORATORIES 's operated at median p/e ratio of 0.45x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INDSWIFT LABORATORIES 's p/e ratio peaked in Mar2025 at 1.03x.
- INDSWIFT LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 0.27x.
How does INDSWIFT LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| INDSWIFT LABORATORIES | 594.5 | 1.85 | 1,102.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.24 | 411,402.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 15.93 | 164,277.0 |
| CIPLA LTD | 28,351.1 | 3.79 | 107,398.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 11.28 | 138,140.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.07 | 106,378.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.17 | 85,818.0 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.55 | 92,654.0 |
| LUPIN LTD | 24,750.7 | 4.08 | 100,999.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.03 | 67,230.7 |
| ABBOTT INDIA LTD | 6,714.4 | 8.45 | 56,703.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs INDSWIFT LABORATORIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.85x |
| Max industry PS | 15.93x |
| Median industry PS | 4.08x |
| Average industry PS | 6.13x |
You may also like the below Video Courses